Genetics of non-alcoholic fatty liver disease and associated metabolic disorders

Lazo, 2008, The epidemiology of nonalcoholic fatty liver disease: a global perspective, Semin Liver Dis, 28, 339, 10.1055/s-0028-1091978 Brunt, 2001, Nonalcoholic steatohepatitis: definition and pathology, Semin Liver Dis, 21, 3, 10.1055/s-2001-12925 Sanyal, 2002, AGA technical review on nonalcoholic fatty liver disease, Gastroenterology, 123, 1705, 10.1053/gast.2002.36572 Daly, 2011, Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease, Expert Rev Gastroenterol Hepatol, 5, 253, 10.1586/egh.11.18 Moreno-Sanchez, 2006, [Epidemiology and natural history of primary nonalcoholic fatty liver disease], Gastroenterol Hepatol, 29, 244 Jakobsen, 2007, Abdominal obesity and fatty liver, Epidemiol Rev, 29, 77, 10.1093/epirev/mxm002 Pagano, 2002, Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association, Hepatology, 35, 367, 10.1053/jhep.2002.30690 Hamaguchi, 2005, The metabolic syndrome as a predictor of nonalcoholic fatty liver disease, Ann Intern Med, 143, 722, 10.7326/0003-4819-143-10-200511150-00009 Marchesini, 2001, Nonalcoholic fatty liver disease: a feature of the metabolic syndrome, Diabetes, 50, 1844, 10.2337/diabetes.50.8.1844 Angelico, 2005, Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease, J Clin Endocrinol Metab, 90, 1578, 10.1210/jc.2004-1024 Targher, 2007, Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients, Diabetes Care, 30, 1212, 10.2337/dc06-2247 Angulo, 1999, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, 30, 1356, 10.1002/hep.510300604 Farrell, 2006, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatology, 432Suppl1, S99, 10.1002/hep.20973 Caballeria, 2010, Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain, Eur J Gastroenterol Hepatol, 22, 24, 10.1097/MEG.0b013e32832fcdf0 Abdelmalek, 2006, Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 4, 1162, 10.1016/j.cgh.2006.06.001 Willner, 2001, Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease, Am J Gastroenterol, 96, 2957, 10.1111/j.1572-0241.2001.04667.x Brouwers, 2009, Heritability of nonalcoholic fatty liver disease, Gastroenterology, 137, 1536, 10.1053/j.gastro.2009.03.065 Schwimmer, 2009, Heritability of nonalcoholic fatty liver disease, Gastroenterology, 136, 1585, 10.1053/j.gastro.2009.01.050 Chalasani, 2010, Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease, Gastroenterology, 139, 1567, 10.1053/j.gastro.2010.07.057 Romeo, 2008, Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nat Genet, 40, 1461, 10.1038/ng.257 Speliotes, 2011, Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits, PLoS Genet, 7, e1001324, 10.1371/journal.pgen.1001324 Yuan, 2008, Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes, Am J Hum Genet, 83, 520, 10.1016/j.ajhg.2008.09.012 Caballero, 2009, Enhanced free cholesterol SREBP-2 and StAR expression in human NASH, J Hepatol, 50, 789, 10.1016/j.jhep.2008.12.016 Guillen, 2009, Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver, Physiol Genomics, 37, 187, 10.1152/physiolgenomics.90339.2008 Miquilena-Colina, 2011, Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C, Gut, 60, 1394, 10.1136/gut.2010.222844 Yoneda, 2008, Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis, Hepatol Res, 38, 1204 Younossi, 2005, A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease, Hepatology, 42, 665, 10.1002/hep.20838 Thomas, 2004 Day, 2005, Genetic studies to identify hepatic fibrosis genes and SNPs in human populations, Methods Mol Med, 117, 315 Day, 1998, Steatohepatitis: a tale of two “hits”?, Gastroenterology, 114, 842, 10.1016/S0016-5085(98)70599-2 Bataller, 2003, Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal, Hepatology, 37, 493, 10.1053/jhep.2003.50127 Cohen, 2011, Human fatty liver disease: old questions and new insights, Science, 332, 1519, 10.1126/science.1204265 Sanyal, 2005, Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease, Nat Clin Pract Gastroenterol Hepatol, 2, 46, 10.1038/ncpgasthep0084 Donnelly, 2005, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J Clin Invest, 115, 1343, 10.1172/JCI23621 Anstee, 2011, Genetics of alcoholic and nonalcoholic Fatty liver disease, Semin Liver Dis, 31, 128, 10.1055/s-0031-1276643 HUGO Gene Nomenclature Committee at the European Bioinformatics Institute. HUGO Gene Nomenclature Committee (HGNC) [consultado 28 Jul 2011]. Disponible en: http://www genenames org. Hernaez, 2011, Hemochromatosis gene and nonalcoholic fatty liver disease: A systematic review and meta-analysis, J Hepatol, 55, 1079, 10.1016/j.jhep.2011.02.013 Soranzo, 2010, Common variants at 10 genomic loci influence hemoglobin A(C) levels via glycemic and nonglycemic pathways, Diabetes, 59, 3229, 10.2337/db10-0502 Huang, 2010, A feed-forward loop amplifies nutritional regulation of PNPLA3, Proc Natl Acad Sci U S A, 107, 7892, 10.1073/pnas.1003585107 Sookoian, 2011, Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease, Hepatology, 53, 1883, 10.1002/hep.24283 Willer, 2008, Newly identified loci that influence lipid concentrations and risk of coronary artery disease, Nat Genet, 40, 161, 10.1038/ng.76 Kantartzis, 2009, Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene, Diabetes, 58, 2616, 10.2337/db09-0279 Zhou, 2010, Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people, J Gastroenterol Hepatol, 25, 772, 10.1111/j.1440-1746.2009.06144.x Jun, 2009, Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans, Eur J Gastroenterol Hepatol, 21, 667, 10.1097/MEG.0b013e3283196adc Dong, 2007, The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population, J Hepatol, 46, 915, 10.1016/j.jhep.2006.12.012 Song, 2005, Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD), FASEB J, 19, 1266, 10.1096/fj.04-3580com Carulli, 2009, Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis, Dig Liver Dis, 41, 823, 10.1016/j.dld.2009.03.005 Musso, 2010, Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis, J Nutr Biochem, 21, 834, 10.1016/j.jnutbio.2009.06.007 Oliveira, 2010, Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease, J Gastroenterol Hepatol, 25, 357, 10.1111/j.1440-1746.2009.06001.x El-Koofy, 2011, Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children, Saudi J Gastroenterol, 17, 265, 10.4103/1319-3767.82582 Namikawa, 2004, Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis, J Hepatol, 40, 781, 10.1016/j.jhep.2004.01.028 Bohme, 2008, MTTP variants and body mass index, waist circumference and serum cholesterol level: Association analyses in 7582 participants of the KORA study cohort, Mol Genet Metab, 95, 229, 10.1016/j.ymgme.2008.09.004 Petersen, 2010, Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease, N Engl J Med, 362, 1082, 10.1056/NEJMoa0907295 Kozlitina, 2011, Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance, Hepatology, 53, 467, 10.1002/hep.24072 Corella, 2002, Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus, J Lipid Res, 43, 416, 10.1016/S0022-2275(20)30148-6 Peng, 2009, [Study on the relationship between FABP2 Ala54Thr polymorphism and the risk of non-alcoholic fatty liver diseases], Wei Sheng Yan Jiu, 38, 401 Aller, 2009, Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease, Eur Rev Med Pharmacol Sci, 13, 357 Zhao, 2010, Association of the fatty acid-binding protein 2 gene Ala54Thr polymorphism with insulin resistance and blood glucose: a meta-analysis in 13451 subjects, Diabetes Metab Res Rev, 26, 357, 10.1002/dmrr.1085 Zhao, 2011, Meta-analysis on the effect of the Ala54Thr polymorphism of the fatty acid-binding protein 2 gene on body mass index, Nutr Metab Cardiovasc Dis, 21, 823, 10.1016/j.numecd.2010.02.020 Zhao, 2010, Ala54Thr polymorphism of fatty acid-binding protein 2 gene and fasting blood lipids: a meta-analysis, Atherosclerosis, 210, 461, 10.1016/j.atherosclerosis.2009.11.049 Kantartzis, 2009, The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans, Clin Sci (Lond), 116, 531, 10.1042/CS20080306 Coudreau, 2003, Role of the DGAT gene C79T single-nucleotide polymorphism in French obese subjects, Obes Res, 11, 1163, 10.1038/oby.2003.160 Ludwig, 2002, DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women, Clin Genet, 62, 68, 10.1034/j.1399-0004.2002.620109.x Kotronen, 2009, Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts, Eur J Endocrinol, 160, 593, 10.1530/EJE-08-0900 Nozaki, 2004, Polymorphisms of interleukin-1 beta and beta 3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis, Alcohol Clin Exp Res, 28 Morcillo, 2008, Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2), Clin Endocrinol (Oxf), 68, 102, 10.1111/j.1365-2265.2007.03006.x Kurokawa, 2008, The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals, Int J Obes (Lond), 32, 1240, 10.1038/ijo.2008.90 Corella, 2001, Gender specific associations of the Trp64Arg mutation in the beta3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation, J Intern Med, 250, 348, 10.1046/j.1365-2796.2001.00894.x Iwamoto, 2001, Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver, Clin Chim Acta, 314, 85, 10.1016/S0009-8981(01)00633-7 Gjesing, 2007, Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects, Diabetologia, 50, 563, 10.1007/s00125-006-0578-8 Jalba, 2008, Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: a meta-analysis, Obesity (Silver Spring), 16, 2096, 10.1038/oby.2008.327 Zhan, 2008, [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease], Zhonghua Gan Zang Bing Za Zhi, 16, 375 Cenarro, 2005, Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response, Am Heart J, 150, 1154, 10.1016/j.ahj.2005.02.006 Isaacs, 2004, The -514 C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis, J Clin Endocrinol Metab, 89, 3858, 10.1210/jc.2004-0188 Kraja, 2011, A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium, Diabetes, 60, 1329, 10.2337/db10-1011 Demirag, 2007, Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease, Dig Dis Sci, 52, 3399, 10.1007/s10620-007-9740-5 Lee, 2002, [Relation of apolipoprotein E polymorphism to clinically diagnosed fatty liver disease], Taehan Kan Hakhoe Chi, 8, 355 Sazci, 2008, Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis, Dig Dis Sci, 53, 3218, 10.1007/s10620-008-0271-5 Yang, 2005, The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver disease, Hepatogastroenterology, 52, 1832 Anthopoulos, 2010, Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls, Mol Genet Metab, 100, 283, 10.1016/j.ymgme.2010.03.008 Sookoian, 2007, Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease, World J Gastroenterol, 13, 4242, 10.3748/wjg.v13.i31.4242 Garaulet, 2009, CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids, Am J Clin Nutr, 90, 1466, 10.3945/ajcn.2009.27536 Dongiovanni, 2010, Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease, Gut, 59, 267, 10.1136/gut.2009.190801 McAteer, 2008, The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects, Diabetes, 57, 1125, 10.2337/db07-1336 Grarup, 2006, Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects, Diabetologia, 49, 2097, 10.1007/s00125-006-0353-x Wang, 2011, ENPP1/PC-1 Gene K121Q Polymorphism Is Associated with Obesity in European Adult Populations: Evidence from A Meta-Analysis Involving 24 324 Subjects, Biomed Environ Sci, 24, 200 Morini, 2009, IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of “low-frequency-low-risk” variants, Diabetologia, 52, 1852, 10.1007/s00125-009-1426-4 Florez, 2004, Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes, Diabetes, 53, 3313, 10.2337/diabetes.53.12.3313 Tokushige, 2009, Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease, J Gastroenterol, 44, 976, 10.1007/s00535-009-0085-z Wang, 2008, Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population, J Endocrinol Invest, 31, 1086, 10.1007/BF03345657 Musso, 2008, Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH, Hepatology, 47, 1167, 10.1002/hep.22142 Wong, 2008, Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people, J Gastroenterol Hepatol, 23, 914, 10.1111/j.1440-1746.2008.05344.x Perez-Martinez, 2008, Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men, J Nutr, 138, 1609, 10.1093/jn/138.9.1609 Gonzalez-Sanchez, 2005, An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance, Obes Res, 13, 807, 10.1038/oby.2005.91 Tso, 2006, Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study, Diabetologia, 49, 1806, 10.1007/s00125-006-0324-2 Yu Z, Han S, Cao X, Zhu C, Wang X, Guo X. Genetic Polymorphisms in Adipokine Genes and the Risk of Obesity: A Systematic Review and Meta-Analysis. Obesity (Silver Spring). 2011 Jun 9. doi:10.1038/oby.2011.148. Dongiovanni, 2010, Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study, BMC Gastroenterol, 10, 102, 10.1186/1471-230X-10-102 Chen, 2008, A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio, J Gastroenterol Hepatol, 23, 1415, 10.1111/j.1440-1746.2008.05523.x Rey, 2010, Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma2 in patients with fatty liver diseases, World J Gastroenterol, 16, 5830, 10.3748/wjg.v16.i46.5830 Huguenin, 2010, The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects, Br J Nutr, 104, 488, 10.1017/S0007114510000851 Gouda, 2010, The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis, Am J Epidemiol, 171, 645, 10.1093/aje/kwp450 Scott, 2007, A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants, Science, 316, 1341, 10.1126/science.1142382 Tonjes, 2006, Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals, Diabetes Care, 29, 2489, 10.2337/dc06-0513 Gonzalez Sanchez, 2002, Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population, Eur J Endocrinol, 147, 495, 10.1530/eje.0.1470495 Huang, 2011, Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: a meta-analysis, Atherosclerosis, 215, 136, 10.1016/j.atherosclerosis.2010.11.043 Barroso, 2006, Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes, Diabetologia, 49, 501, 10.1007/s00125-005-0130-2 Musso, 2009, Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH, Hepatology, 49, 426, 10.1002/hep.22659 Gonzalez-Sanchez, 2008, Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population, Diabetologia, 51, 1993, 10.1007/s00125-008-1129-2 Hu, 2010, Variants from GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1 SLC30A8 and IGF1 are associated with glucose metabolism in the Chinese, PLoS One, 5, e15542, 10.1371/journal.pone.0015542 Ingelsson, 2010, Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans, Diabetes, 59, 1266, 10.2337/db09-1568 Liu, 2009, Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults, J Clin Endocrinol Metab, 94, 3575, 10.1210/jc.2009-0609 Yang, 2011, Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people, Mol Biol Rep, 38, 1145, 10.1007/s11033-010-0212-1 Nettleton, 2010, Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies, Diabetes Care, 33, 2684, 10.2337/dc10-1150 Onuma, 2010, The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population, J Hum Genet, 55, 600, 10.1038/jhg.2010.75 Dupuis, 2010, New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk, Nat Genet, 42, 105, 10.1038/ng.520 Saxena, 2010, Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge, Nat Genet, 42, 142, 10.1038/ng.521 Saxena, 2007, Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, Science, 316, 1331, 10.1126/science.1142358 Haupt, 2009, Impact of variation near MC4R on whole-body fat distribution, liver fat, and weight loss, Obesity (Silver Spring), 17, 1942, 10.1038/oby.2009.233 Scherag, 2010, Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german stu*dy gro*ups, PLoS Genet, 6, e1000916, 10.1371/journal.pgen.1000916 Wang, 2010, Association of the MC4R V103I polymorphism with obesity: a Chinese case-control study and meta-analysis in 55,195 individuals, Obesity (Silver Spring), 18, 573, 10.1038/oby.2009.268 Willer, 2009, Six new loci associated with body mass index highlight a neuronal influence on body weight regulation, Nat Genet, 41, 25, 10.1038/ng.287 Loos, 2008, Common variants near MC4R are associated with fat mass, weight and risk of obesity, Nat Genet, 40, 768, 10.1038/ng.140 Young, 2007, The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals, Int J Obes (Lond), 31, 1437, 10.1038/sj.ijo.0803609 Geller, 2004, Melanocortin-4 receptor gene variant I103 is negatively associated with obesity, Am J Hum Genet, 74, 572, 10.1086/382490 Oruc, 2009, Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease, Ann Hepatol, 8, 116, 10.1016/S1665-2681(19)31788-0 Lu, 2009, Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China, J Gastroenterol Hepatol, 24, 228, 10.1111/j.1440-1746.2008.05544.x De Luis, 2008, Influence of Lys656Asn polymorphism of the leptin receptor gene on insulin resistance in nondiabetic obese patients, J Diabetes Complications, 22, 199, 10.1016/j.jdiacomp.2006.10.006 Portoles, 2006, Effect of genetic variation in the leptin gene promoter and the leptin receptor gene on obesity risk in a population-based case-control study in Spain, Eur J Epidemiol, 21, 605, 10.1007/s10654-006-9045-6 Heo, 2002, A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference, Int J Obes Relat Metab Disord, 26, 640, 10.1038/sj.ijo.0801990 Heo, 2001, Pooling analysis of genetic data: the association of leptin receptor (LEPR) polymorphisms with variables related to human adiposity, Genetics, 159, 1163, 10.1093/genetics/159.3.1163 Paracchini, 2005, Genetics of leptin and obesity: a HuGE review, Am J Epidemiol, 162, 101, 10.1093/aje/kwi174 Aller, 2010, G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients, Ann Hepatol, 9, 439, 10.1016/S1665-2681(19)31620-5 Hu, 2009, Tumor necrosis factor--alpha gene promoter polymorphisms in Chinese patients with nonalcoholic fatty liver diseases, Acta Gastroenterol Belg, 72, 215 Tokushige, 2007, Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis, J Hepatol, 46, 1104, 10.1016/j.jhep.2007.01.028 Valenti, 2002, Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease, Gastroenterology, 122, 274, 10.1053/gast.2002.31065 Sookoian, 2005, Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome, Obes Res, 13, 2122, 10.1038/oby.2005.263 Qi, 2006, Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis, Hum Mol Genet, 15, 1914, 10.1093/hmg/ddl113 Qi, 2007, Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals, J Clin Endocrinol Metab, 92, 3618, 10.1210/jc.2007-0877 Brun, 2006, Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region, Gut, 55, 1212, 10.1136/gut.2006.093336 Fernandez-Real, 2003, CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity, J Clin Endocrinol Metab, 88, 1780, 10.1210/jc.2002-020173 Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, et al. The sod2 c47t polymorphism influences nafld fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol. 2011 Jul 11.[ahead of print]. Iwata, 2011, A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease, Clin Sci (Lond), 120, 287, 10.1042/CS20100246 Sookoian, 2009, Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease, J Nutr Biochem, 20, 765, 10.1016/j.jnutbio.2008.07.005 Wang, 2011, The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population, Liver Int, 31, 1326, 10.1111/j.1478-3231.2011.02526.x Nakayama, 2009, Large scale replication analysis of loci associated with lipid concentrations in a Japanese population, J Med Genet, 46, 370, 10.1136/jmg.2008.064063 Bille, 2011, Implications of Central Obesity-Related Variants in LYPLAL1, NRXN3 MSRA, and TFAP2B on Quantitative Metabolic Traits in Adult Danes, PLoS One, 6, e20640, 10.1371/journal.pone.0020640 Heid, 2010, Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution, Nat Genet, 42, 949, 10.1038/ng.685 Hotta, 2010, Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1 FTO and MC4R and their effect on visceral fat area in the Japanese population, J Hum Genet, 55, 738, 10.1038/jhg.2010.99 Lindgren, 2009, Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution, PLoS Genet, 5, e1000508, 10.1371/journal.pgen.1000508 Dunn, 2006, Examination of PPP1R3B as a candidate gene for the type 2 diabetes and MODY loci on chromosome 8p23, Ann Hum Genet, 70, 587, 10.1111/j.1469-1809.2005.00248.x Luo, 2011, Fasting-induced protein phosphatase 1 regulatory subunit contributes to postprandial blood glucose homeostasis via regulation of hepatic glycogenesis, Diabetes, 60, 1435, 10.2337/db10-1663 Teslovich, 2010, Biological, clinical and population relevance of 95 loci for blood lipids, Nature, 466, 707, 10.1038/nature09270